BioXyTran
Needham
About BioXyTran
BioXyTran operates as a biopharmaceutical company whose mission is to develop anti-necrosis drugs that treat a variety of medical conditions resulting from stroke and Ischemia. The company was founded in 2008 and is headquartered in Needham, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2026)
- Ticker: otcpink:BIXT
- Website: bioxytraninc.com
- Phone: 617-454-1199
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bioxytran-2241428 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.